Corina Mihaela Manta

Dr. Corina Mihaela Manta

SARA Pharm Solutions, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2017 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
OCOvidiu-Ilie Covaci
Ovidiu-Ilie Covaci
Raul - Augustin MitranRaul - Augustin Mitran
Raul - Augustin Mitran
LBLucian Buhalteanu
Lucian Buhalteanu
DDDan George Dumitrescu
Dan George Dumitrescu
SSSergiu Shova
Sergiu Shova
CMCorina Mihaela Manta
Corina Mihaela Manta
This paper describes the rational search for and the synthesis of eight new polymorphs, solvates or hydrates of the well-known drug nifuroxazide. By selecting the appropriate polymorph, a 50% increase in solubility was obtained, compared to the commercially available solid form. The target molecule was chosen using hydrogen bond propensity models as a rational approach. All new forms were characterized by X-ray powder diffraction and thermal methods, and, in three cases, by single crystal X-ray diffraction. Two new solid anhydrous polymorphs were discovered and showed a significant increase in solubility and dissolution rates in water over the known solid form.

29 July 2021 in Crystal Growth & Design
Verified
Journal Article
Closed access
DSDumitru Samohvalov
Dumitru Samohvalov
MLMaria-Andreea Lungan
Maria-Andreea Lungan
SSSergiu Shova
Sergiu Shova
ABAdrian Bărbatu
Adrian Bărbatu
Daniel GhercaDaniel Gherca
Daniel Gherca
CMCorina Mihaela Manta
Corina Mihaela Manta

11 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YVYan Voloshin
Yan Voloshin
SDSemyon V. Dudkin
Semyon V. Dudkin
SBSvetlana A. Belova
Svetlana A. Belova
DGDaniel Gherca
Daniel Gherca
DSDumitru Samohvalov
Dumitru Samohvalov
Vladimir ArionVladimir Arion
Vladimir Arion
The in situ spectroelectrochemical cyclic voltammetric studies of the antimony-monocapped nickel(II) and iron(II) tris-pyridineoximates with a labile triethylantimony cross-linking group and Zr(IV)/Hf(IV) phthalocyaninate complexes were performed in order to understand the nature of the redox events in the molecules of heterodinuclear zirconium(IV) and hafnium(IV) phthalocyaninate-capped derivatives. Electronic structures of their 1e-oxidized and 1e-electron-reduced forms were experimentally studied by electron paramagnetic resonance (EPR) spectroscopy and UV−vis−near-IR spectroelectrochemical experiments and supported by density functional theory (DFT) calculations. The investigated hybrid molecular systems that combine a transition metal (pseudo)clathrochelate and a Zr/Hf-phthalocyaninate moiety exhibit quite rich redox activity both in the cathodic and in the anodic region. These binuclear compounds and their precursors were tested as potential catalysts in oxidation reactions of cyclohexane and the results are discussed.

Verified
Journal Article
Open access
PDF file
NTn'ghaya toulbe
n'ghaya toulbe
ISIon Smaranda
Ion Smaranda
CNConstantin-Catalin Negrila
Constantin-Catalin Negrila
Maria Cristina BarthaMaria Cristina Bartha
Maria Cristina Bartha
CMCorina Mihaela Manta
Corina Mihaela Manta
Mihaela BaibaracMihaela Baibarac
Mihaela Baibarac
The effect of sodium thiosulfate (ST) on the photodegradation of azathioprine (AZA) was analyzed by UV-VIS spectroscopy, photoluminescence (PL), FTIR spectroscopy, Raman scattering, X-ray photoelectron (XPS) spectroscopy, thermogravimetry (TG) and mass spectrometry (MS). The PL studies highlighted that as the ST concentration increased from 25 wt.% to 75 wt.% in the AZA:ST mixture, the emission band of AZA gradual downshifted to 553, 542 and 530 nm. The photodegradation process of AZA:ST induced: (i) the emergence of a new band in the 320–400 nm range in the UV-VIS spectra of AZA and (ii) a change in the intensity ratio of the photoluminescence excitation (PLE) bands in the 280–335 and 335–430 nm spectral ranges. These changes suggest the emergence of new compounds during the photo-oxidation reaction of AZA with ST. The invoked photodegradation compounds were confirmed by studies of the Raman scattering, the FTIR spectroscopy and XPS spectroscopy through: (i) the downshift of the IR band of AZA from 1336 cm−1 to 1331 cm−1, attributed to N-C-N deformation in the purine ring; (ii) the change in the intensity ratio of the Raman lines peaking at 1305 cm−1 and 1330 cm−1 from 3.45 to 4.57, as the weight of ST in the AZA:ST mixture mass increased; and (iii) the emergence of a new band in the XPS O1s spectrum peaking at 531 eV, which was associated with the C=O bond. Through correlated studies of TG-MS, the main key fragments of ST-reacted AZA are reported.

3 October 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
ABAdrian Bărbatu
Adrian Bărbatu
MLMaria-Andreea Lungan
Maria-Andreea Lungan
NTn'ghaya toulbe
n'ghaya toulbe
ISIon Smaranda
Ion Smaranda
MDMONICA DAESCU
MONICA DAESCU
CMCorina Mihaela Manta
Corina Mihaela Manta
The physico-chemical properties of two anhydrous AZA forms and their interaction with typical pharmaceutical excipients were assessed by applying various methods (such as PXRD, HPLC, TG/DSC, IR, Raman, PL or UV-Vis) in order to highlight new directions for drug formulation. The stability assessment of AZA anhydrous forms I and II was performed in order to determine the risk of degradation of the active ingredient by accidental exposure to non-standard conditions in the industrial environment, under different storage, transport or processing conditions. The benefits of form II include increased resistance to chemical degradation over a wide range of pH, but further control of storage and processing conditions is necessary to avoid polymorphic transformation into form I. The solubility assessment on the AZA solid forms in different environments that simulate the conditions of the gastrointestinal tract has the advantage of a significantly increased solubility of form II compared with the commercial form I due to the modification of the crystalline structure. In the case of capsules compared to AZA form I or II as powder, an improvement in their solubility was observed, promoted by the presence of one or more excipients in the formulation mixture.